Biomarkers in the Critically Ill Patient: C-reactive Protein

Critical Care Clinics

Volumn 27, Issue 2, 2011, Pages 241-251

  Vincent, Jean Louis ^a   Donadello, Katia ^a   Schmit, Xavier ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Antibiotic; C reactive protein; Cirrhosis; Infection; Organ failure; Outcome; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PLACEBO; PROCALCITONIN; ROSUVASTATIN;

ACUTE PHASE RESPONSE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CANDIDIASIS; CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; GRAM NEGATIVE SEPSIS; GRAM POSITIVE INFECTION; HUMAN; INFECTION; INFLAMMATION; INTENSIVE CARE; LABORATORY TEST; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; TREATMENT OUTCOME; VIRUS INFECTION;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; HUMANS; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS;

EID: 79953008613     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.12.010     Document Type: Review

References (77)

1. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
2. Tillett W.S., Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930, 52:561-571.
3. Ash R. Nonspecific precipitins for pneumococcic fraction C in acute infections. J Infect Dis 1933, 53:89-97.
4. Abernethy T.J., Avery O.T. The occurrence during acute infections of a protein not normally present in the blood: I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J Exp Med 1941, 73:173-182.
5. Macleod C.M., Avery O.T. The occurrence during acute infections of a protein not normally present in the blood: II. Isolation and proerties of the reactive protein. J Exp Med 1941, 73:183-190.
6. Thompson D., Pepys M.B., Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999, 7:169-177.
7. Shine B., De Beer F.C., Pepys M.B. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981, 117:13-23.
8. Raitakari M., Mansikkaniemi K., Marniemi J., et al. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: the cardiovascular risk in young Finns study. J Intern Med 2005, 258:428-434.
9. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
10. Vigushin D.M., Pepys M.B., Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993, 91:1351-1357.
11. Mold C., Rodriguez W., Rodic-Polic B., et al. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol 2002, 169:7019-7025.
12. Szalai A.J., Nataf S., Hu X.Z., et al. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol 2002, 168:5792-5797.
13. Mold C., Gewurz H., Du Clos T.W. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999, 42:23-30.
14. Casey R., Newcombe J., McFadden J., et al. The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun 2008, 76:1298-1304.
15. Shephard E.G., Beer S.M., Anderson R., et al. Generation of biologically active C-reactive protein peptides by a neutral protease on the membrane of phorbol myristate acetate-stimulated neutrophils. J Immunol 1989, 143:2974-2981.
16. Clapp B.R., Hirschfield G.M., Storry C., et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005, 111:1530-1536.
17. Nakagomi A., Freedman S.B., Geczy C.L. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 2000, 101:1785-1791.
18. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
19. Szalai A.J., Agrawal A., Greenhough T.J., et al. C-reactive protein: structural biology and host defense function. Clin Chem Lab Med 1999, 37:265-270.
20. Szalai A.J., VanCott J.L., McGhee J.R., et al. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun 2000, 68:5652-5656.
21. Zouaoui Boudjeltia K., Piagnerelli M., Brohee D., et al. Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?. Thromb J 2004, 2:7.
22. Black S., Kushner I., Samols D. C-reactive protein. J Biol Chem 2004, 279:48487-48490.
23. Dessein P.H., Joffe B.I., Stanwix A.E. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J Rheumatol 2004, 31:1095-1097.
24. Benhamou M., Gossec L., Dougados M. Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein. Rheumatology (Oxford) 2010, 49:536-541.
25. Mendoza J.L., Abreu M.T. Biological markers in inflammatory bowel disease: practical consideration for clinicians. Gastroenterol Clin Biol 2009, 33(Suppl 3):S158-S173.
26. Imamura T., Tanaka S., Yoshida H., et al. Significance of measurement of high-sensitivity C-reactive protein in acute pancreatitis. J Gastroenterol 2002, 37:935-938.
27. Pongprasobchai S., Jianjaroonwong V., Charatcharoenwitthaya P., et al. Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis. Pancreas 2010, 39(8):1226-1230.
28. Qian F.H., Zhang Q., Zhou L.F., et al. High-sensitivity C-reactive protein: a predicative marker in severe asthma. Respirology 2008, 13:664-669.
29. Dahl M. Genetic and biochemical markers of obstructive lung disease in the general population. Clin Respir J 2009, 3:121-122.
30. Kalhan R., Tran B.T., Colangelo L.A., et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One 2010, 5:e11431.
31. Daniels J.M., Schoorl M., Snijders D., et al. Procalcitonin versus C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 2010, 138(5):1108-1115.
32. Lofstrom G. Non-specific capsular swelling in pneumococci. Acta Med Scand 1942, 110:49-55.
33. De Beer F.C., Hind C.R., Fox K.M., et al. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982, 47:239-243.
34. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
35. Ridker P.M., Buring J.E., Shih J., et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731-733.
36. Cushman M., Arnold A.M., Psaty B.M., et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005, 112:25-31.
37. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
38. Marshall J.C., Reinhart K. Biomarkers of sepsis. Crit Care Med 2009, 37:2290-2298.
39. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
40. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256.
41. Ugarte H., Silva E., Mercan D., et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27:498-504.
42. Povoa P., Coelho L., Almeida E., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005, 11:101-108.
43. Pulliam P.N., Attia M.W., Cronan K.M. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 2001, 108:1275-1279.
44. Sierra R., Rello J., Bailen M.A., et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 2004, 30:2038-2045.
45. Peres Bota D., Melot C., Lopes F.F., et al. Infection probability score (IPS): a method to help assess the probability of infection in critically ill patients. Crit Care Med 2003, 31:2579-2584.
46. Martini A., Gottin L., Melot C., et al. A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unit. J Infect 2008, 56:313-318.
47. Lannergard A., Friman G., Ewald U., et al. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr 2005, 94:1198-1202.
48. Povoa P., Coelho L., Almeida E., et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 2006, 10:R63.
49. Bota D.P., Van Nuffelen M., Zakariah A.N., et al. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005, 146:347-351.
50. Silvestre J.P., Coelho L.M., Povoa P.M. Impact of fulminant hepatic failure in C-reactive protein?. J Crit Care 2010, 25(4):657. e7-12.
51. Timonen T.T., Koistinen P. C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia. Eur J Cancer Clin Oncol 1985, 21:557-562.
52. Toikka P., Irjala K., Juven T., et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000, 19:598-602.
53. Flood R.G., Badik J., Aronoff S.C. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J 2008, 27:95-99.
54. Almirall J., Bolibar I., Toran P., et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004, 125:1335-1342.
55. Martini A., Gottin L., Menestrina N., et al. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010, 60:425-430.
56. Vandijck D.M., Hoste E.A., Blot S.I., et al. Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis 2007, 7:106.
57. Silvestre J., Povoa P., Coelho L., et al. Is C-reactive protein a good prognostic marker in septic patients?. Intensive Care Med 2009, 35:909-913.
58. Lobo S.M., Lobo F.R., Bota D.P., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
59. Ho K.M., Dobb G.J., Lee K.Y., et al. C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. J Crit Care 2006, 21:259-265.
60. Ho K.M., Lee K.Y., Dobb G.J., et al. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 2008, 34:481-487.
61. Grander W., Dunser M., Stollenwerk B., et al. CRP levels and post-intensive care unit mortality in non-surgical intensive care patients. Chest 2010, 138(4):856-862.
62. Al-Subaie N., Reynolds T., Myers A., et al. C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 2010, 105:318-325.
63. Menendez R., Cavalcanti M., Reyes S., et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 2008, 63:447-452.
64. Yentis S.M., Soni N., Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995, 21:602-605.
65. Ehl S., Gering B., Bartmann P., et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997, 99:216-221.
66. Bomela H.N., Ballot D.E., Cory B.J., et al. Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis. Pediatr Infect Dis J 2000, 19:531-535.
67. Schmit X., Vincent J.L. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008, 36:213-219.
68. Lisboa T., Seligman R., Diaz E., et al. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008, 36:166-171.
69. Bruns A.H., Oosterheert J.J., Hak E., et al. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008, 32:726-732.
70. Venkatesh B., Kennedy P., Kruger P.S., et al. Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation. Anaesth Intensive Care 2009, 37:20-26.
71. Muller B., Becker K.L., Schachinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28:977-983.
72. Luzzani A., Polati E., Dorizzi R., et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741.
73. Uzzan B., Cohen R., Nicolas P., et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
74. Castelli G.P., Pognani C., Cita M., et al. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009, 37:1845-1849.
75. Simon L., Gauvin F., Amre D.K., et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
76. Gaini S., Koldkjaer O.G., Pedersen C., et al. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006, 10:R53.
77. Tang B.M., Eslick G.D., Craig J.C., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.